ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Abstract Number: 473
    RA Presents in Disease Patterns Impacting Treatment Response
  • Abstract Number: 64
    Rab4A Controls mTOR Pathway Activation, Pro-inflammatory Lineage Development, and Disease Pathogenesis in Lupus-prone Mice
  • Abstract Number: 82
    Rab4A Increases Mitochondrial Oxidative Stress and Glutathione Disulfide Accumulation That Underlie Neurobehavioral Changes in Lupus-Prone Mice
  • Abstract Number: PP05
    Race for Relapsing Polychondritis Drives Awareness, Accelerates Research, and Improves the Quality of My Life: How Motorsports Help Me Overcome the Hopelessness of an Incurable, Rare Disease
  • Abstract Number: 1853
    Racial Differences in Highly Effective Contraceptive Use Among Medicaid Beneficiaries with SLE
  • Abstract Number: 1143
    Racial Disparities in Factors Associated with SLICC Damage Score Among Patients with SLE
  • Abstract Number: 1141
    Racial Disparities in Lupus Medication Adherence
  • Abstract Number: 1848
    Racial Disparities in Septic and Aseptic Total Knee Replacement Revision Risk: A Study Using Four State-wide Inpatient Databases
  • Abstract Number: 584
    Radiographic Association of Hip and SI Joints in Ankylosing Spondylitis Patients
  • Abstract Number: 2849
    Radiographic Progression During a 10-Year Follow-Up : Results from the French Cohort ESPOIR
  • Abstract Number: 2219
    Randomized Control Study in Glucocorticoid-Induced Osteoporosis Treated with Bisphosphonate or Denosumab (GOBID)
  • Abstract Number: 2878
    Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Phase 2b Study to Demonstrate the Safety and Efficacy of Tildrakizumab, a High-Affinity Anti–Interleukin-23P19 Monoclonal Antibody, in Patients with Active Psoriatic Arthritis
  • Abstract Number: 350
    Rapid Reduction in Uric Acid Is Associated with Recurrent Cardiovascular Events
  • Abstract Number: 952
    Rate of Thirty-Day Readmissions in Systemic Lupus Erythematosus Rivals Congestive Heart Failure and Exceeds the General Medicare Population
  • Abstract Number: 1301
    Rates of Incident Radiographic Knee Osteoarthritis and Knee Replacement by Sex and Race, Across Three Large, Diverse Cohorts
  • Abstract Number: 2451
    Rates of Myocardial Infarction, Stroke, and Revascularization Among Patients with Psoriatic Arthritis Treated with Apremilast, Biologics, DMARDs, and Corticosteroids in the US MarketScan Database
  • Abstract Number: 2441
    Rates of Treated Depression Among Patients with Psoriatic Arthritis Treated with Apremilast, Biologics, DMARDs, and Corticosteroids in the US MarketScan Database
  • Abstract Number: 2660
    Rationalizing the Use of MRI of the Scalp Arteries in the Diagnosis of Giant Cell Arteritis Through Multivariable Predictive Modelling
  • Abstract Number: 1313
    Readmissions After Staged vs Simultaneous Bilateral Total Knee Replacements (TKR)
  • Abstract Number: 1495
    Real Life 12 Year Retention Rate of Subcutaneous Anti-TNF in Spondyloarthritis. Results from a Multicenter Cohort of 1170 Patients
  • Abstract Number: 2686
    Real Life Data over 4 Years from a Fast Track GCA Pathway in Coventry
  • Abstract Number: 1400
    Real Life Retention of Tofacitinib in Patients with Rheumatoid Arthritis
  • Abstract Number: 2112
    Real Life Serious Infections in Patients with Chronic Inflammatory Arthritis on Treatment with TNF Inhibitors
  • Abstract Number: 1530
    Real World Effectiveness of Secukinumab in Patients with Ankylosing Spondylitis: Findings from a Recent Cross Sectional Survey of Rheumatologists and Patients in Europe
  • Abstract Number: 1443
    Real World Switching Patterns of Etanercept Original and Biosilmilar in Germany
  • Abstract Number: 1431
    Real-Life Golimumab Persistence in Patients with Chronic Inflammatory Rheumatic Disease: Results of the GO PRACTICE Study
  • Abstract Number: 2684
    Real-world Comparative Study of Methotrexate vs Tocilizumab in Patients with Giant Cell Arteritis with Large Vessel Involvement
  • Abstract Number: 2352
    Real-World Distribution of Anti-Cyclic Citrullinated Peptide Concentrations and Impact on Treatment Patterns of Patients with Rheumatoid Arthritis
  • Abstract Number: 244
    Real-World Evidence Associated with the Treatment of Systemic Lupus Erythematosus in the USA, UK, France, and Germany: A Structured Review
  • Abstract Number: 419
    Real-World Evidence on the Early Effects of Golimumab on Work Productivity and Activity Impairment in Patients with Spondyloarthritis: Interim Results from a Prospective, Observational Study
  • Abstract Number: 204
    Real-World Evidence: Clinical and Economic Burden of Anemia, Venous Thromboembolism, and Malignancy Among Rheumatoid Arthritis Patients Switching from First Biologic DMARD to Another Treatment in the US
  • Abstract Number: 1374
    Real-World Evidence: Infections Among RA Patients Switching from First Biologic DMARD to Another Treatment in the US
  • Abstract Number: 1205
    Real-World Remission Outcomes in the First Year Following RA Diagnosis Vary Considerably with the Disease Activity Index Used and a Sizable Proportion Have Persistent Active Disease Across All Measures: Results from the Canadian Early Arthritis Cohort (CATCH)
  • Abstract Number: 2444
    Real-world Treatment Patterns Among Patients with Psoriatic Arthritis Treated with Biologic Therapies
  • Abstract Number: 1481
    Real-World Use of Apremilast in Combination with Biologic Therapy in Patients with Psoriatic Arthritis: Findings from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
  • Abstract Number: 2698
    Reasons for Initiation of Canakinumab of Patients with Systemic Juvenile Idiopathic Arthritis: A Retrospective Medical Chart Review from the United States
  • Abstract Number: 203
    Recent Use, Missed Doses and Discontinuation of Infliximab in a Population-Based Cohort: Comparisons of Biosimilar and Originator Exposures
  • Abstract Number: PP04
    Reclaiming Medical Autonomy Through Healthcare Advocacy
  • Abstract Number: 631
    Recognition of Inflammatory Back Pain by US Healthcare Providers and Barriers to Specialist Referral
  • Abstract Number: 1257
    Recommendation on Colchicine Dosing and Definition of Colchicine Resistance/Intolerance in the Management of Familial Mediterranean Fever
  • Abstract Number: 2485
    Red Cell Distribution Width Positively Correlates with Atherosclerotic Cardiovascular Disease Risk Score in Psoriatic Arthritis and Decreases with BDMARD Therapy
  • Abstract Number: 736
    Reduced Circulating Levels of Inorganic Pyrophosphate Are Associated with Ectopic Calcification in Scleroderma Spectrum Disorders
  • Abstract Number: 1916
    Reduced DNASE1L3 Activity in Sporadic SLE Is Linked to Increased DNA Load of Microparticles, Reactivity to DNASE1L3-sensitive Antigens, and Lupus Nephritis
  • Abstract Number: 1664
    Reducing the Number of Rituximab Infusions at Onset of Maintenance Therapy for ANCA-associated Vasculitides: Results of a Post Hoc Analysis from a Randomized–controlled Trial
  • Abstract Number: 1422
    Reduction in CD4 TEMRA Cells and Its Association with DAS28 (CRP) < 2.6 Treatment Response with Abatacept in Patients with Early, ACPA+, DMARD-Naïve RA
  • Abstract Number: 935
    Reduction of Anterior Uveitis Flares in Patients with Axial Spondyloarthritis Following 1 Year of Treatment with Certolizumab Pegol: 48-Week Interim Results from a 96-Week Open-Label Study
  • Abstract Number: 2189
    Reference Curves for the Knee Injury and Osteoarthritis Outcome Score in the Middle-aged Dutch Population
  • Abstract Number: 2471
    Regional Difference in Disease Burden Among Patients with Psoriatic Arthritis: A Multi-Center Study
  • Abstract Number: 1976
    Regulation of Interleukin-1β (IL-1β)-induced COX-2 Expression and IL-6 and MMP-1 Production in Human OA Synovial Fibroblasts by Guanylate Binding Protein 5
  • Abstract Number: 31
    Regulation of Neutrophil Extracellular Traps by Apremilast (phosphodiesterase 4 Inhibition)
  • Abstract Number: 1014
    Regulatory Role of IL-23 and Its Receptor System in Spondyloarthritis and Its Therapeutic Relevance in anti-IL-17 Failure Patients
  • Abstract Number: 948
    Relapsing Cryoglobulinemic Vasculitis Following Successful HCV Eradication by Interferon-Free Direct Acting Antivirals, an International Multicenter Study
  • Abstract Number: 2183
    Relation of Intra-Articular Knee Mineralization on CT to Knee Pain in People with or at Risk of Knee Osteoarthritis
  • Abstract Number: 2182
    Relation of MRI-detected Structural Damage in the Knee to Anterior Knee Pain: The MOST Study
  • Abstract Number: 1315
    Relation of MRI-detected Structural Damage in the Patellofemoral Joint to Pain and Performance Based Function: The MOST Study
  • Abstract Number: 619
    Relation of Therapies for Ankylosing Spondylitis to Risk of Total Hip and Knee Arthroplasty
  • Abstract Number: 213
    Relationship Between a History of Abuse and Fibromyalgia Symptoms and Severity: Data from the Cleveland Clinic Fibromyalgia Registry
  • Abstract Number: 1440
    Relationship Between Adalimumab Concentrations, Plasma Cytokines, Anti-drug Antibodies and Disease Activity in Rheumatoid Arthritis
  • Abstract Number: 710
    Relationship Between High-Resolution Computer Tomography and FVC% Predicted for Classification of Pulmonary Hypertension in Systemic Sclerosis
  • Abstract Number: 2610
    Relationship Between Parenchymal and Vascular Features in Systemic Sclerosis-Interstitial Lung Disease: Results from Quantitative Analysis of Chest Computed Tomography
  • Abstract Number: 138
    Relationship Between Recurrent Thrombosis and the Antiphospholipid Antibodies Profile in a Cohort of Patients with Antiphospholipid Syndrome
  • Abstract Number: 2470
    Relationship Between Serum Calprotectin Level and Presence of Subclinical Atherosclerosis and Arterial Stiffness in Patient with Psoriatic Arthritis
  • Abstract Number: 2210
    Relationship Between Structural Spine Involvement and the Scanographic Bone Attenuation Coefficient of L1 in a Population of 73 Patients with Ankylosing Spondylitis
  • Abstract Number: 1362
    Relationship Between Waking Functions and Disease Activity in Rheumatoid Arthritis Patients Analyzed by Wearable Device
  • Abstract Number: 1633
    Relationship Between YKL-40, VEGF, and IL-5 in Borderline mPAP and Pulmonary Hypertension in Systemic Sclerosis
  • Abstract Number: 1105
    Relationships Among Cognitive Emotion Regulation, Body Image, Family and Marital Function and Quality of Life in Chinese Female Patients with Systemic Lupus Erythematosus
  • Abstract Number: 1222
    Relationships Between Allopurinol Dose, Oxypurinol Levels and Serum Urate – in Search of an Oxypurinol Therapeutic Concentration
  • Abstract Number: 2382
    Relationships Between DAS28 Response and Clinical, Functional and Radiographic Outcomes in Year 2 of the COMET Study of Etanercept in Patients with Rheumatoid Arthritis
  • Abstract Number: 2514
    Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
  • Abstract Number: 2513
    Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
  • Abstract Number: 2465
    Reliability and Validity of the Self‐Administered Comorbidity Questionnaire in Psoriatic Arthritis
  • Abstract Number: 1832
    Reliability of Traditional Cardiovascular Risk Calculators in Predicting Risk of Cardiovascular Disease in Systemic Sclerosis
  • Abstract Number: 2840
    Reliability, Validity and Responsiveness of PROMIS PF-20 in Patients with Inflammatory Myopathy
  • Abstract Number: 1684
    Remission and Low Disease Activity State in Patients with Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual
  • Abstract Number: 2908
    Remission in Patients with Rheumatoid Arthritis Receiving Triple Therapy Compared to Biological Therapy – A Swedish Nationwide Register Study
  • Abstract Number: 1564
    Renal Arteriosclerosis Predicts Cardiovascular Disease in Lupus Nephritis
  • Abstract Number: 2786
    Renal Histopathological Classifications Predict the Renal Outcomes of Plasma Exchange-Treated ANCA-Associated Vasculitides with Renal Failure
  • Abstract Number: 1018
    Renal Single Cell Genomics Links Type II Interferon and Lupus Nephritis in African-Americans
  • Abstract Number: 335
    Renal Transplant Complications in Patients with and Without Gout
  • Abstract Number: 236
    Repeat Muscle Pressures Measured in Fibromyalgia Patients and Compared with Pain Scores
  • Abstract Number: 592
    Replacement of Radiographic Sacroilitis by MRI Structural Lesions: What Is the Impact on Classification of Axial Spondyloarthritis in the ASAS Classification Cohort?
  • Abstract Number: 2354
    Replication of a Prognostic Multivariable Prediction Model for Insufficient Clinical Response to Methotrexate in Early Rheumatoid Arthritis
  • Abstract Number: 2169
    Reporting of Adverse Events in Randomized Controlled Trials of Therapeutic Exercise for Knee Osteoarthritis: A Systematic Review
  • Abstract Number: 2282
    Reproductive Counseling Documentation Practices for Women Receiving Teratogenic Medications in an Academic Rheumatology Clinic Serving a Medicaid/Medicare Patient Population
  • Abstract Number: 2239
    Reproductive Health Awareness and Needs: Assessment of Parents, Female Adolescents, and Young Adults with Pediatric Rheumatic Diseases
  • Abstract Number: 2280
    Reproductive Health Intention Screening in Women with Systemic Rheumatic Diseases: Low Uptake and Gender-Specific Provider Patterns Following a Standardized Intervention
  • Abstract Number: 1528
    Resolution of Enthesitis and Dactylitis Is Maintained over Two Years of Ixekizumab Treatment in Patients with Psoriatic Arthritis
  • Abstract Number: 1841
    Resolution of Vascular Inflammation in Patients with Giant Cell Arteritis Receiving Glucocorticoids, Methotrexate or Tocilizumab Treatment: Data from the Italian/German RIGA Study
  • Abstract Number: 2735
    Response Gene to Complement -32 Exerts Proinflammatory and Profibrotic Effects in Immune Complex Gediated Glomerulonephritis
  • Abstract Number: 1279
    Response Rate and Sustained Remission in Idiopathic Inflammatory Myopathies Receiving Conventional Immunosuppressive Stepwise Management
  • Abstract Number: 940
    Response to Placebo in Randomized Clinical Trials with Biologics in Non-renal, Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Pooled Analysis
  • Abstract Number: 2678
    Response to Tocilizumab in Patients with Giant Cell Arteritis, According to Ischemic vs Systemic Symptoms
  • Abstract Number: 2617
    Responsiveness to Change of the Modified Rodnan Skin Score in a Phase I/II Double-Blind Randomized Placebo-Controlled Trial
  • Abstract Number: 1179
    Resting-State Functional Connectivity of Pain Processing Brain Region Associated with Therapeutic Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis
  • Abstract Number: 578
    Restricted Work Participation Relates to High Disease Activity in Spondyloarthritis Patients
  • Abstract Number: 2089
    Restricting Activity to Evade Knee Symptoms Is Associated with Worse Physical Function and Radiographic Osteoarthritis
  • Abstract Number: 1429
    Results at 6 Months of Abatacept vs TNF-α Blockers in Patients with Severe, Long-standing, DMARDs Resistant Rheumatoid Arthritis
  • Abstract Number: 824
    Results from a Randomized Controlled Trial of the Safety of the Live Varicella Vaccine in TNF-Treated Patients
  • Abstract Number: 2232
    Results of the Implementation of a Bone Health Program in Patients with Rheumatoid Arthritis to Improve the Evaluation of Osteoporosis
  • Abstract Number: 2544
    Results of the Open-label, Non-randomized 52-Week Study to Evaluate Treatment Holidays and Rebound Phenomenon After Treatment with Belimumab in Patients with SLE
  • Abstract Number: 1512
    Retention Rates and Response of Anti-TNF Treatments in the Enteropathic Spondylitis: HUR-BIO Real Life Results
  • Abstract Number: 611
    Retina of Ankylosing Spondylitis Patients Shows Early Signs of Atherosclerotic Disease in Comparison with Healthy Controls
  • Abstract Number: 383
    Retroperitoneal Fibrosis- a Single Center Experience
  • Abstract Number: 1783
    Reversible Dysregulation of Renal Circadian Rhythm in Lupus Nephritis
  • Abstract Number: 1757
    Review of Effectiveness of an Intensive Rehabilitation Programme in Managing Strength, Pain and Function in 123 Young People with Rheumatological Conditions
  • Abstract Number: 699
    Revising the SLEDAI-2K to Include Additional Constitutional Symptoms to More Accurately Assess Lupus Disease Activity
  • Abstract Number: 582
    Rheumacheck – Spondyloarthritis: Comprehensive Fast-track Diagnosis Program. What Benefits Does It Offer in a Developing Country?
  • Abstract Number: 2125
    Rheumatic Fever in a Tertiary Medical Center – 25 Years of Follow Up
  • Abstract Number: 2158
    Rheumatic Immune Related Adverse Events Associated with Cancer Immunotherapy: A Nationwide Multi-centre Canadian Cohort from the Canadian Research Group of Rheumatology in Immuno-oncology (CanRIO)
  • Abstract Number: 2138
    Rheumatic Immune-related Adverse Effects from Checkpoint Inhibitor Immunotherapy in Patients with Solid Tumors in a Latin American Population
  • Abstract Number: 2139
    Rheumatic Immune-Related Adverse Events Associated with Treatment with Immune Checkpoint Inhibitors: A Multicenter Study of 38 Cases
  • Abstract Number: 1810
    Rheumatic Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Retrospective, Pharmacovigilance Study
  • Abstract Number: 1184
    Rheumatoid Arthritis Activity Assessment with Cellphone Thermal Camera Imaging Compared to Clinical and Ultrasound Assessments
  • Abstract Number: 260
    Rheumatoid Arthritis Associated with Longer Hospital Stays in Patients Admitted with Venous Thromboembolism: A Nationwide Analysis 2010-2014
  • Abstract Number: 2228
    Rheumatoid Arthritis Disease Activity Is Associated with Low Femoral Neck Bone Mineral Density in a Diverse Cohort of Patients
  • Abstract Number: 1898
    Rheumatoid Arthritis in Pregnancy and Offspring School Performance. a Danish Nationwide Register-Based Study
  • Abstract Number: 877
    Rheumatoid Arthritis Patients’ Perspectives on Tapering of Biologics: A Qualitative Study
  • Abstract Number: 550
    Rheumatoid Arthritis Treatment with Filgotinib: Week 156 Safety and Efficacy Data from a Phase 2b Open-Label Extension Study
  • Abstract Number: 342
    Rheumatologist Care Is Associated with Fewer Emergency Room Visits by Persons with Gout
  • Abstract Number: 1112
    Rheumatologists’ Opinions and Use of Telemedicine in the Southwestern U.S
  • Abstract Number: 1797
    Rheumatology Mechanism Madness: A Pilot Collaborative Learning Activity for Rheumatology Trainees
  • Abstract Number: 2905
    Rilonacept in Recurrent Pericarditis: Efficacy and Safety Data from an Ongoing Phase 2 Pilot Clinical Trial
  • Abstract Number: 734
    Risk Assessment in Connective Tissue Disease Associated Pulmonary Arterial Hypertension
  • Abstract Number: 202
    Risk Factors Associated with Serious Infections Among Users of Biosimilar and Originator Infliximab Therapies
  • Abstract Number: 1607
    Risk Factors for Avascular Necrosis in SLE: A Multivariate Model
  • Abstract Number: 351
    Risk Factors for Cutaneous Reactions to Allopurinol in Kinh Vietnameses: Results of a Prospective Study in Ho Chi Minh City
  • Abstract Number: 2114
    Risk Factors for Cytomegalovirus Infection in Patients with Autoimmune Diseases
  • Abstract Number: 1306
    Risk Factors for Pain After Total Joint Replacement in Osteoarthritis: Different Pain Measures, Distinct Predictors?
  • Abstract Number: 2170
    Risk Factors for Poor Outcomes After Hip Fracture Patients in the Robust Elderly: Are Patient Reported Outcomes Important?
  • Abstract Number: 2108
    Risk Factors for Pulmonary Nontuberculous Mycobacterial Disease in Rheumatoid Arthritis Patients
  • Abstract Number: 2300
    Risk Factors for Transfusion and Use of Tranexemic Acid in Patients with Rheumatoid Arthritis Undergoing Total Hip Arthroplasty and Total Knee Arthroplasty
  • Abstract Number: 1840
    Risk Factors for Treatment Failure in Patients with Giant Cell Arteritis Treated with Tocilizumab Plus Prednisone versus Prednisone Alone
  • Abstract Number: 1283
    Risk Factors of Cancer-Associated Inflammatory Myopathies: A Multicenter Study
  • Abstract Number: 2872
    Risk of 30-day Readmission and Adverse Events After Primary Hip or Knee Arthroplasty: A Comparison of Patients with Rheumatoid Arthritis versus Osteoarthritis Using the Nationwide Readmission Database
  • Abstract Number: 2781
    Risk of Cardiovascular Disease Associated with the Use of Glucocorticoids in Patients with Incident Systemic Lupus Erytematosus: A Population-based Study
  • Abstract Number: 805
    Risk of Cardiovascular Disease in SLE Is Significant Early and Highlights Racial Disparities
  • Abstract Number: 2365
    Risk of Diabetes Treatment Switching or Intensification Associated with Use of Abatacept versus Other Biologic Drugs in Patients with Rheumatoid Arthritis and Diabetes Mellitus
  • Abstract Number: 2368
    Risk of Diverticulitis and Gastro-Intestinal Perforation in Rheumatoid Arthritis Treated with Tocilizumab Compared to Rituximab and Abatacept: A Prospective Propensity-matched Cohort Study
  • Abstract Number: 732
    Risk of Heart Valve Disease in Systemic Sclerosis
  • Abstract Number: 1395
    Risk of Immunization to Rituximab in Systemic Autoimmune Diseases and Rheumatoid Arthritis: Frequency and Risk Factors. Analysis of the Efficacy of an Alternative Treatment by Ofatumumab
  • Abstract Number: 1339
    Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis
  • Abstract Number: 2333
    Risk of Incident Myocardial Infarction Among Disabled Patients with Rheumatoid Arthritis Who Were Beneficiaries of the Social Security Disability Insurance
  • Abstract Number: 2434
    Risk of Lymphoma and Thyroid Cancer in Primary Sjögren’s Syndrome Measured Using the Korean Health Insurance Claims Database
  • Abstract Number: 2371
    Risk of Malignancies Across Biologic Classes in Rheumatoid Arthritis: Analysis of a National Claim Database
  • Abstract Number: 849
    Risk of Malignancies Associated with Biologics in Rheumatoid Arthritis: Analysis of a National Claim Database
  • Abstract Number: 2053
    Risk of Non-vertebral Fracture in Gout Compared to Rheumatoid Arthritis
  • Abstract Number: 2675
    Risk of Potential Glucocorticoid-Related Adverse Events in Patients with Giant Cell Arteritis: Results from a US-based Electronic Health Records Database
  • Abstract Number: 1091
    Risk of Preterm Birth by Timing of Lupus Diagnosis Among Women in the Georgia Lupus Registry
  • Abstract Number: 848
    Risk of Serious Infection with Long-Term Use of Low-Dose Glucocorticoids in Patients with Rheumatoid Arthritis
  • Abstract Number: 2273
    Risk of Serious Infections in Offspring According to TNFi Subtypes
  • Abstract Number: 2826
    Risk of Serious Infections in Tofacitinib versus Other Biologic Drug Initiators in Patients with Rheumatoid Arthritis: A Multi-database Cohort Study
  • Abstract Number: 196
    Risk of Subsequent Atherosclerotic Cardiovascular Disease After the First Unprovoked Venous Thromboembolism in Patients with Rheumatoid Arthritis
  • Abstract Number: 2393
    Risk of Thromboembolism with Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis of Randomized Placebo Controlled Trials
  • Abstract Number: 1686
    Risk of Vasculitis Associated with Inflammatory Bowel Diseases: Evidence for a Role of TNF-α Blockers
  • Abstract Number: 1894
    Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Initiating Biologic and Non-biologic DMARDs, a Population-based Study
  • Abstract Number: 2697
    Risk Score of Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis
  • Abstract Number: 2904
    Rituximab as Rescue Therapy in Treatment-Refractory CTD-ILD
  • Abstract Number: 2619
    Rituximab for Eosinophilic Granulomatosis with Polyangiitis: A Systematic Review of Observational Studies
  • Abstract Number: 793
    Rituximab for Rapidly Progressive Juvenile Systemic Sclerosis: A Proof-of-concept Study in Four Patients
  • Abstract Number: 740
    Rituximab Rescue Therapy in Patients with Systemic Sclerosis or Other Connective Tissue Diseases and Refractory Interstitial Lung Disease
  • Abstract Number: 2131
    Rituximab Safety and Persistence in Patients with Systemic Autoimmune Diseases
  • Abstract Number: 2141
    Rituximab Therapy for Interstitial Pneumonia with Autoimmune Features (IPAF): A Case Series of Nineteen Patients
  • Abstract Number: 2521
    Rituximab Treatment Is Not Associated with Increased Risk of Infection or Mortality in Refractory SLE Patients: Results from the British Isles Lupus Assessment Group Biologics Registry (BILAG-BR)
  • Abstract Number: 1000
    RKIP, as an Upstream Regulator of Intracellular Signaling, Exerts Anti-arthritic Effect in Fibroblast-like Synoviocyte and Collagen-induced Arthritis
  • Abstract Number: 1036
    RNA Sequencing of PBMCs Reveals Estrogen-Mediated Upregulation of Micro-RNA Processing Machinery
  • Abstract Number: 2045
    RNA Sequencing of Plasma and Urine-derived Extracellular Vesicles from Lupus Nephritis Patients Identifies Disease-associated Small RNA Signatures and Putative Therapeutic Targets
  • Abstract Number: 1595
    Role of Aerobic Exercise in Modulating Fatigue in Women with Systemic Lupus Erythematosus
  • Abstract Number: 371
    Role of Alternative Immunosuppressant Therapy in Management of Cardiac Sarcoidosis
  • Abstract Number: 2238
    Role of Clinical Impact, Disease-specific Knowledge and Beliefs About Medication on Therapeutic Adherence in Rheumatoid Arthritis: An Integrative Structural Equation Modeling Approach
  • Abstract Number: 2154
    Role of Insulin Resistance and Inflammation on Resting Energy Expenditure in Patients with Rheumatoid Arthritis
  • Abstract Number: 1927
    Role of Mitochondrial DNA from OA Patients in Cellular Apoptosis, Senescence and Autophagy
  • Abstract Number: 39
    Role of Sialic Acid in the Aggressive Phenotype of RA FLS
  • Abstract Number: 2420
    Role of T Follicular Helper Cells and T Peripheral Helper Cells in the Activation of B Cells in Sjögren Syndrome
  • Abstract Number: 24
    Role of Trained Immunity in the Pathogenesis of Erdheim-Chester Disease
  • Abstract Number: 10
    Roles of Histone Acetyltransferases CBP/p300 and Transcriptional Factor RORα/REV-ERBα Against TNFα-induced CCL2 Expression in RA-FLSs
  • Abstract Number: 1877
    Romosozumab Improves Lumbar Spine Bone Mineral Density and Bone Strength Greater Than Alendronate as Assessed by Quantitative Computed Tomography and Finite Element Analysis in the ARCH Trial
  • Abstract Number: 2424
    RORγt Antagonist Attenuates Experimental Sialadenitis Like Sjögren’s Syndrome via Inhibition of CD25 Expression on CD4+ T Cells
  • Abstract Number: 1559
    Routine Clinical Pathology Measurements Are Predictive of the Risk of Organ Damage Accrual in SLE
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences